November 2009 in “Eclética Química” In this study, a potentiometric titration method was developed for determining minoxidil, achieving recoveries of 97.4% to 98.7%, and it showed agreement with a chromatographic procedure at a 90% confidence level.
December 2024 in “IntechOpen eBooks” This source discusses drug repurposing, which seeks new therapeutic uses for existing drugs, emphasizing its benefits like faster development, reduced costs, and novel treatments for unmet medical needs. The chapter outlines current trends and future perspectives in drug discovery through repurposed drugs.
August 2022 in “IARS international research journal” This review discusses drug repurposing for various conditions, including cancer and COVID-19, highlighting ongoing trials with potential repurposed drugs but provides no new clinical results.
January 2023 in “Brazilian Journals Editora eBooks”
1 citations
,
May 2017 in “Hair transplant forum international” This paper discusses the recent online debate over the use of PRP in hair restoration but provides no new findings.
2 citations
,
June 2003 in “PubMed” The two finasteride formulations are bioequivalent.
May 2026 in “The Bioscan.” This review discusses the process and advantages of drug repurposing, highlighting its potential to expedite development and improve therapeutic outcomes with examples like sildenafil and metformin.
May 2023 in “Reactions Weekly” January 2013 in “Reactions Weekly” January 2023 in “Revista Ibero-Americana de Humanidades, Ciências e Educação” This source explores treatments for male-pattern baldness, highlighting finasteride, which reduces DHT levels to support hair growth, and minoxidil, used for vasodilation and hair health, though the exact mechanisms remain partly unclear.
January 2026 in “RSC Advances” This study used a zebrafish model and advanced mass spectrometry to identify 11 metabolites of epristeride, revealing significant effects on purine metabolism and aromatic amino acid biosynthesis, which may aid in developing anti-doping detection methods.
31 citations
,
August 2001 in “PubMed” This study found that the TrichoScan method detected significant increases in hair counts and cumulative hair thickness in men after finasteride treatment, suggesting its potential for monitoring hair treatment responses.
December 2025 in “Al-Azhar International Medical Journal /Al-Azhar International Medical Journal” This study compared the diagnostic effectiveness of Folliscope and Trichoscope in 100 men with androgenetic alopecia, concluding that using both methods enhances diagnostic accuracy by providing complementary insights—Trichoscope highlights patterns while Folliscope offers objective measurements.
October 2025 in “Open Repository of the University of Porto (University of Porto)”
8 citations
,
March 2016 in “Hair transplant forum international” This article discusses hair angle manipulation using the Mega FUE® device but reports no clinical results; disclosure of the author's ownership of the manufacturing company is noted.
This source discusses the growing trend of drug repurposing, a strategy that seeks new uses for existing drugs to overcome challenges like lengthy timelines and high costs in the traditional drug development process.
May 2022 in “Reactions Weekly” April 2023 in “Al-Azhar International Medical Journal /Al-Azhar International Medical Journal” This study found that both trichoscopy and folliscopy are highly accurate for diagnosing telogen effluvium, but trichoscopy is easier and quicker to perform.
July 2023 in “International Journal of Molecular Sciences” In this study, Trapa bispinosa Roxb. pericarp extract demonstrated inhibitory effects on 5α-reductase activity both in vitro using LNCaP cells and in vivo in a mouse model of benign prostatic hyperplasia, suggesting its potential role in managing the condition.
February 2013 in “Journal of The American Academy of Dermatology” Finasteride solution helps treat hair loss.
12 citations
,
January 1993 in “PubMed” This review discusses the pharmacology and clinical use of finasteride for benign prostatic hyperplasia and reports its effectiveness in reducing prostate size and symptoms, though success varies among patients.
March 2026 in “Frontiers in Pharmacology” The study concluded that the Exprecell™ device for preparing anticoagulant-free f-PRF increases volume yield and simplifies the process while maintaining biological activity comparable to conventional methods, suggesting potential clinical utility.
January 2012 in “Pharmacy Today” This study concluded that two formulations of finasteride were bioequivalent based on Cmax, AUC, and Tmax data from healthy volunteers.
February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This document promotes a 10% discount code for Beauty by Earth's natural skincare products, providing details on applying the discount and highlighting the benefits of their eco-friendly offerings, with no new research findings reported.
February 2025 in “International Journal of Impotence Research” July 2022 in “Zenodo (CERN European Organization for Nuclear Research)” This promotional text about hair replacement options near Lauderdale Lakes argues against hair plugs, implants, laser transplants, and robotic surgery but provides no clinical research findings.
13 citations
,
April 2013 in “Chinese Chemical Letters/Chinese chemical letters” This study developed and validated a sensitive HPLC–MS/MS method for detecting seven prohibited substances in cosmetic products.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This review outlines the evolution of drug repurposing from accidental discoveries to a systematic approach enhanced by genomics and data analytics, emphasizing its accelerated relevance during the COVID-19 pandemic and exploring its global and Indian milestones, computational strategies, and future regulatory perspectives.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study reports the discovery of LX-38, a novel non-steroidal drug candidate that may offer safer treatment for conditions like Benign Prostatic Hyperplasia by avoiding hormonal side effects associated with current therapies.